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Introduction: Breast density, the fibroglandular, non-fatty tissue in the breast, has been shown to be a 
significant risk factor for breast cancer. Little is currently known about the predictors of breast density among 
the understudied but increasing population of Hispanic and Latino women in the United States.  
Objectives: The objective of this study is to identify predictors of breast density among Hispanic and Latino 
women in Connecticut and to determine if these differ from those described in other populations. Because the 
hormonal milieu is somewhat different in Hispanic/Latinas compared with White women, we are interested in 
how these variables impact breast density. We are primarily interested in the role of reproductive and 
physiological factors. 
Methods: We analyzed for breast density predictors in an established cohort of 1,600 Hispanic and Latino 
women recruited from primary care clinics in Connecticut. Baseline interview questions provided prospective 
data on biological, medical care, and sociodemographic factors. Subjects provided informed consent for the 
retrieval of mammography reports from screening facilities during the follow-up period. These reports 
provided breast density information based on radiologist assigned BI-RADS classification. Associations 
between predictors and breast density were examined with descriptive statistics and chi square statistical tests 
for which p-values were reported. We additionally calculated odds ratios and 95% confidence intervals using 
logistic regression modeling.  
Results: Breast density data were collected for 1,040 women (65.4%). 280 women (27%) were identified as 
having dense breasts while 760 women (73%) were classified as having nondense breasts based on screening 
mammogram reports. In the multivariate model, breast density predictors were generally consistent with those 
reported in previous studies. Additionally, we found women with diabetes to be at significantly reduced odds 
of breast density. There was also evidence that the relationship between age at menarche and density was 
modified by BMI. 
Conclusion: Our findings suggest that Hispanic and Latino women differ in breast density distribution relative 
to the general population. Additionally, we observed the protective effect of diabetes and potential interaction 
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between age at menarche and BMI. This investigation enhances our understanding of breast density in 
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Breast cancer is the most common form of cancer among women in the United States and the 
second leading cause of cancer mortality among Americans (1, 2). In 2016, an estimated 246,660 cases 
and more than 40,000 deaths from breast cancer are projected in the United States (3). Among Hispanic 
and Latino women, breast cancer incidence is lower when compared to White and Black women, yet it is 
the most common cause of cancer mortality in this population (3, 4).  
Breast density, referring to the fibroglandular, non-fatty tissue in the breast, is known to be one of 
the strongest predictors of breast cancer incidence (5, 6). Studies show a minimum three to four fold 
increase in breast cancer risk among women with dense breasts relative to women without dense breasts 
(6-8). Meta-analyses performed by McCormack and Silva show consistent findings across 42 studies of 
the significant association between density and breast cancer (5). Research also suggests a protective 
effect of fatty, nondense tissue against the development of cancer (9, 10).  
Because of its association with higher risk of breast cancer and lowered sensitivity of screening 
mammograms, breast density is required by law in several states, including Connecticut, to be routinely 
disclosed on mammography reports. Density is assessed on screening mammograms through the Breast 
Imaging Reporting and Data System (BI-RADS) created by the American College of Radiology to 
categorize breast density (11). BI-RADS reflects a subjective assessment and categorization of the 
proportion of dense tissue relative to fatty tissue in the breast. Radiologists will classify the breast tissue 
into one of four categories: predominantly fatty, scattered fibrogladular densities, heterogeneously dense, 
and extremely dense (11). 
Although numerous studies have been performed with regard to breast density in White and 
Black women, Hispanic and Latino women living in the United States remain understudied (12). To our 
knowledge, there is only one published study that has addressed breast density in Hispanic and Latino 
women living in the Northeast region of the United States, however the sample size of this group was 
small (n=81) and Hispanic and Latino women were not the primary focus of the study (13). Cross 
sectional studies have provided some insight regarding the association between breast density and breast 
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cancer risk factors (such as age, menopause status, weight, and hormone replacement therapy) in this 
population (14). Others have included Hispanic and Latino women in their analyses but examined specific 
associations with dietary factors and body composition (12, 15). A number of previous studies 
additionally give sole focus to women of Mexican ancestry (16-19). 
In the United States, the Hispanic and Latino population are the largest non-majority group, with 
their numbers expected to grow over the next several decades (20). Given increases in the population size 
of this group and cultural, demographic, and ancestral differences among Hispanic and Latino women 
living in the northeast, there are significant public health implications associated with the identification of 
the risk factors of breast density in this population, such as educational awareness and necessary access 
healthcare resources. In this exploratory analysis, we aim to report the distribution of breast density in 
Hispanic and Latino women living in four residential enclaves of Connecticut and identify significant 
biological, reproductive, and sociodemographic predictors of breast density in the population.  
 
Materials and Methods 
Data Sources 
Data were collected as part of a larger prospective cohort study, Cancer Screening in Hispanic/ 
Latinas Living in the Northeast, U.S. (RO1CA134276, Beth A. Jones, PI). The main objectives of this 
study were to examine predictors of mammographic screening behavior and adherence to screening 
guidelines during a 2.5 to 4 year follow-up period. Eligible participants were recruited from one of eleven 
participating primary care facilities in Waterbury, New Haven, Hartford, and Bridgeport, four of the 
largest enclaves for Hispanic and Latino populations in Connecticut according to U.S. Census Bureau 
data (21). Working within these facilities at different times and days of the week, our bilingual, bicultural 
research staff recruited women who self-identified as Hispanic or Latino and met the eligibility criteria 
for this study. Of the nearly 1,600 women (n=1,591 remained in the final data set) who provided baseline 
data, 98% provided written consent allowing investigators to access and review mammography reports 
and all relevant correspondence with regard to the mammogram results. Bilingual research staff 
conducted hour-long interviews with study subjects via telephone. We collected extensive information of 
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sociodemographic, medical history, acculturation, sociocultural, and mammography screening data, as 
well as known predictors of breast density and established breast cancer risk factors. We accessed 
mammographic radiology reports and images for 1,569 women from facilities identified by the 
respondent as a place she had received mammography in the past, would seek a mammogram in the 
future, or from all mammography facilities in the city in which she was recruited. Although it is not a 
closed system, there is a relatively low number of large facilities that provide all mammography services 
in these urban areas. All activities in this study were approved by the Yale Human Investigation 
Committee, in addition to all research oversight committees at participating facilities.    
Study Population 
We targeted the four cities in Connecticut with the largest Hispanic/Latino populations 
(Waterbury, New Haven, Hartford, and Bridgeport). Our study sample includes Hispanic and Latino 
women who presented at participating primary care clinics (hospital based and Federally Qualified Health 
Centers [FHQCs]) in these areas and who were between the ages of 40-75 at the time of enrollment. 
Additional eligibility criteria included that participants have no medical history of breast cancer, breast 
biopsy, or cyst aspiration. Of the 2,137 eligible Hispanic/Latino women who we identified, 1,591 (74.5%) 
provided baseline interviews. Of the women who we were able to contact after the initial enrollment, our 
participation rate was 92%. Study subjects were limited to the 1,569 (98.6%) who provided signed 
consent to review radiology records. Mammographic data were available for 1,040 study participants who 
received at least one screening mammogram during the follow-up study period. Because state law 
mandates that breast density is recorded and shared with patients, 100% of screening mammogram reports 
included density information. For women who received more than one screening mammogram, breast 
density was recorded for each exam report retrieved. 
Measures and Definitions 
Dependent Variable 
Based on the BI-RADS classification system, breast density, as listed on screening 
mammograms, was categorized as fatty, scattered fibroglandular densities, heterogeneously dense, and 
extremely dense. For most analyses, a dichotomized breast density variable (dense versus nondense) was 
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utilized. Women reported as having extremely or heterogeneously dense breasts were categorized as 
“dense”, while women in the fatty or scattered density categories were classified as “nondense”. For 
participants for whom multiple reports were retrieved during follow-up, changes in breast density 
measures across tests and over time were anticipated. Previous studies show that density tends to decrease 
over time (i.e. with age) (22, 23). As a result, we relied on the assumption that density would not increase 
over the follow up period. Discrepancies in BI-RADS reported density over time may have been a result 
of variation in radiologist interpretation of the mammographic images. For our purposes, if earlier reports 
indicated a woman had nondense breasts, and a single later report indicated dense breasts, the participant 
was categorized as “nondense” as it is more likely and biologically plausible that density would decrease 
over time, not increase. As expected, some women transitioned from having dense breasts to less dense 
breasts over time (with age). Thus, women whose earlier mammograms were classified as dense and later 
transitioned to nondense were considered dense for the purpose of our analysis. 
Independent Variables 
Baseline characteristics 
 Baseline sociodemographic variables included age (<50, ≥50 years old), marital status (single, 
married/partnered), education level (less than high school, some college or more), income 
(<$10,000/year, $10,000-14,999, ≥$15,000), and employment status (yes, no). Access to care variables 
were insurance status (none, public only, other coverage), usual care provider (yes, no), self-rated health 
(fair/poor, good/very good), and mammogram in the last year (yes, no). Acculturation variables included 
number of years lived in the United States (U.S. born, <10 years in U.S., ≥10 years in U.S.), self-rated 
spoken English (no English/not well, very well), and country of origin (U.S. born, foreign born, Puerto 
Rican born). 
Reproductive and Physiological Variables 
Women who reported having completed menopause (no menses for previous 12 months) or 
whose periods had ceased due to hormone replacement therapy, hysterectomy, or oophorectomy were 
categorized as postmenopausal. Those who had a period in the previous 12 months were categorized as 
premenopausal. Women who reported that they were in the process of going through menopause were 
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categorized as perimenopausal. Women were also classified (yes, no) based on hormone replacement 
therapy use, hysterectomy/oophorectomy status, regular exercise (at least one time per week), diabetes 
status (ever been told by a doctor that they had diabetes; of note, 94% of women who self-reported 
diabetes diagnosis also reported insulin use and/or oral medication), history of infertility (trying for one 
year or more without getting pregnant), family history of breast cancer (among primary relatives), and 
alcohol consumption in the last year. BMI categories (normal/underweight, obese, and overweight) were 
created from continuous, height and weight data. Although these data were self-reported by participants, 
in general the information was read from a card that was filled out at the time of the primary care 
appointment and reflected current, measured height and weight at the time of the appointment. The mean 
number of live births in this sample was 4 births, and as such, parity was categorized as nulliparous, <4, 
and ≥4 live births. Age at first birth was also collected as a continuous variable (mean age being 19 years 
old) and later stratified into three groups, nulliparous, <19, and, ≥19. Breastfeeding was assessed through 
the cumulative number of months that a woman breastfed. The strata included never breastfed, <12 
months, and ≥12 months. Women with no children were included in the “never breastfed” strata. 
Additional variables in the analysis were consumption of traditional Hispanic/Latino diet (less than 
weekly, 1-3 times per week, 4-6 times per week, everyday), sum of comorbidities (0-1, 2,3,>3), bra size 
(A, B, C, D, DD or larger), and oral contraceptive use (never used, ≤4 years, >4 years).  
 
Statistical Analysis 
Bivariate analyses were conducted using chi square, for which p-values were reported, and 
logistic regression.  Baseline characteristics were adjusted for age while reproductive and physiological 
variables were adjusted for age and BMI. Total number of comorbidities and diabetes were adjusted with 
age, a continuous variable for BMI, and bra size, in order to control for residual confounding. 
Multivariate logistic regression was performed to calculate odds ratios and 95% confidence intervals to 
determine associations between significant baseline characteristics and all reproductive and physiological 
factors and breast density. We used stepwise elimination and set significance levels for which variables 
entered and exited the model to 0.1 and 0.15 respectively. Additionally, education was forced into this 
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multivariate model in order to control for socioeconomic factors that were not included in the analysis. 
Possible interactions with age and BMI were tested among significant variables using stratified analyses 
and the Breslow-Day test for homogeneity. For these analyses, BMI was dichotomized 
(normal/underweight, obese/overweight). A categorical variable for age at menarche was created based on 
the average age at menarche reported by women in the cohort (>12, ≤12 years old). Interaction terms were 
also tested in the multivariate model. All analyses and data management were conducted using SAS 
version 9.4. 
Results 
Of the women who received screening mammograms during the follow-up period (n=1,040), 
16.4% were reported as having fatty breasts, 56.6% with scattered fibroglandular densities, 25% with 
heterogeneously dense breasts, and 2% with extremely dense breasts (Table 1, Figure 1). With 
categorization of the breast density variable into “dense” and “nondense”, we report that 280 (27%) had 
dense breasts and 760 (73%) had nondense breasts.  
 
Table 1: Distribution of BI-RADS breast density in Hispanic/Latino women in Connecticut (n=1,040) 
BI-RADS Category Frequency  % 
Fatty (0 - <25%)a 171 16.4 
Scattered with fibroglandular densities 
(25-50%) 
589 56.6 
Heterogeneous (51-75%) 260 25.0 
Extremely (>75%) 20  2.0 








Descriptive data by breast density are shown in Table 2. The distribution of breast density in the 
cohort differed significantly by age group, marital status, income, employment, insurance status, whether 
or not a mammogram was received in the last year, and by country of origin. Women younger than 50 
years old were more likely to have dense breasts relative to women aged 50 years or older. Participants 
who reported being unemployed, single, receiving public insurance, having a mammogram in the last 
year, and earning a low income (particularly women who earned less than $10,000 per year) were found 
to be at significantly reduced odds of having dense breasts. Women born outside the continental United 
States but living in the United States for over ten years were at 1.59 times the odds of having dense 
breasts relative to women who were born within the United States. Women born outside the continental 
United States but living in the United States for less than 10 years were also at 1.59 times the odds of 
having dense breasts however this association was not significant. Puerto Rican born (OR = 1.33, 95% CI 
0.87 – 2.04) and foreign born (OR = 2.11 95% CI 1.34 – 3.31) participants were at increased odds of 
density relative to those born in the United States. Once adjusted for age, marital status, income, and 
insurance status were not significantly associated with density. After adjusting for age, breast density was 
still significantly lower among women who received a mammogram in the last year and women who were 
unemployed. Women living in the United States for over 10 years were at significantly increased odds of 
























for less than 10 years showed only a marginally significant association with breast density (OR = 1.74, 
95% CI, 1.00 – 3.02). Foreign born women were at 2.32 (95% CI 1.46 – 3.69) times the odds of having 
dense breasts, while women born in Puerto Rico were at 1.68 (95% CI 1.08 – 2.60) times the odds of 
dense breasts compared to women born in the United States. No significant associations were found 
between density and English language skill, self-rated health, having a usual care provider, and level of 
education. 
 
Table 2: Descriptive characteristics of cohort by breast density 
Characteristic n (%)a Denseb 
Breasts  




(n = 760) 
 
OR (95% CI) p-valuec 
 
Age Adjusted  
OR (95%CI) 
Sociodemographic        
Age (years)       
    <50 443 (42.6) 171 (61.1) 272 (35.8) 2.81 (2.12 – 3.73) <.0001 -- 
   ≥50 597 (57.4) 109 (38.9) 488 (64.2) 1.00   
Marital status       
    Single 686 (66.0) 166 (59.3) 520 (68.4) 0.67 (0.51 – 0.89) 0.0058 0.77 (0.58 – 1.03) 
    Married/Partnered 354 (34.0) 114 (40.7) 240 (31.6) 1.00  1.00 
Education Level       
    <12 years 568 (54.8) 143 (51.2) 425 (56.1) 0.82 (0.62 – 1.08) 0.1608 1.01 (0.76 – 1.35) 
   ≥12 years 468 (45.2) 136 (48.8) 332 (43.9) 1.00  1.00 
Income       
    <$10, 000 495 (50.2) 115 (43.1) 380 (52.8) 0.57 (0.41 – 0.80) 0.0043d 0.73 (0.52 – 1.05) 
    $10,000-$14,999 247 (25.0) 67 (25.1) 180 (25.0) 0.70 (0.48 – 1.03)  0.78 (0.52 – 1.15) 
    $15,000+ 245 (24.8) 85 (31.8) 160 (22.2) 1.00  1.00 
Employment       
    No 762 (73.3) 177 (63.2) 585 (77.0) 0.51 (0.38 – 0.69) <0.0001 0.63 (0.47 – 0.86) 
    Yes 278 (26.7) 103 (36.8) 175 (23.0) 1.00  1.00 
Access to Care       
Insurance Status       
    None 169 (16.3) 59 (21.1) 110 (14.5) 1.03 (0.62 – 1.72) 0.0037 1.03 (0.61 – 1.74) 
    Public only 764 (73.6) 185 (66.0) 579 (76.4) 0.61 (0.40 – 0.95)  0.64 (0.41 – 1.00) 
    Other Coverage 105 (10.2) 36 (12.9) 69 (9.1) 1.00  1.00 
Usual Care Provider       
    No 487 (47.1) 134 (48.0) 353 (46.8) 1.05 (0.79 – 1.38) 0.7290 1.05 (0.80 – 1.39) 
    Yes 546 (52.9) 145 (52.0) 401 (53.2) 1.00  1.00 
Self-rated Health       
    Fair/Poor 570 (56.4) 151 (55.5) 419 (56.8) 0.95 (0.72 – 1.26) 0.7201 0.93 (0.70 – 1.24) 
    Good/Excellent 440 (43.6) 121 (44.5) 319 (43.2) 1.00  1.00 
Mammogram in Last Year       
    No 336 (32.5) 77 (27.7) 259 (34.3) 0.73 (0.54 – 0.99) 0.0444 0.67 (0.49 – 0.91) 
    Yes 697 (67.5) 201 (72.3) 496 (65.7) 1.00  1.00 
Acculturation       
Acculturation       
    ≥10 years in U.S. 736 (71.4) 209 (74.9) 527 (70.1) 1.59 (1.05 – 2.40) 0.0836 1.96 (1.28 – 3.00) 
    <10 years in U.S. 130 (12.6) 37 (13.3) 93 (12.4) 1.59 (0.93 – 2.73)  1.74 (1.00 – 3.02) 
    U.S. Born 165 (16.0) 33 (11.8) 132 (17.5) 1.00  1.00 
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Self-rated Spoken English       
    None/not well 784 (86.9) 215 (84.3) 569 (87.9) 0.74 (0.49 – 1.11) 0.1453 1.01 (0.66 – 1.55) 
    Very well 118 (13.1) 40 (15.7) 78 (12.1) 1.00  1.00 
Country of Origin       
    Puerto Rico 584 (56.2) 146 (52.3) 438 (57.6) 1.33 (0.87 -2.04) 0.0011d 1.68 (1.08 – 2.60) 
    Foreign born 290 (27.9) 100 (35.9) 190 (25.0) 2.11 (1.34 – 3.31)  2.32 (1.46 – 3.69) 
    US Born 165 (15.9) 33 (11.8) 132 (17.4) 1.00  1.00 
aAs a result of missing data, numbers may not sum to totals.  
bDense defined as having heterogeneously or extremely dense breasts according to BI-RADS (>50% dense).  
cp-values from chi-square tests.  
dSignificant trend p-value. 
 
Reproductive and physiological variables are listed in Table 3 by breast density. Perimenopausal 
(OR = 1.89, 95% CI 1.06 – 3.36) and premenopausal women (OR = 3.04, 95% CI 2.23 – 4.08) were at 
significantly increased odds of having dense breasts relative to postmenopausal women. After adjusting 
for age and BMI, only premenopausal status was significantly associated with density. Relative to 
nulliparous women, women with higher parity (≥4 births) had reduced odds while women with lower 
parity (<4 births) were at increased odds of having dense breasts. In the unadjusted and adjusted bivariate 
models, the effect of parity was not significant. Hormone replacement therapy and receipt of a bilateral 
oophorectomy were significantly inversely associated with having dense breasts. Women who reported 
having a history of infertility were at significantly higher odds of having dense breasts relative to women 
with no history of infertility. Adjusting for age and BMI, neither hormone replacement therapy, 
oophorectomy status, nor history of infertility were associated with density. We observed a significant 
trend in increasing number of comorbidities and increased bra size with lower breast density (p<0.0001). 
Higher BMI and having diabetes were also significantly protective (p<0.0001). After adjustment, diabetes 
and increasing bra size remained protective while total number of comorbidities was no longer associated 
with density. Age at menarche, oral contraceptive use, age at first birth, duration of breastfeeding, family 
history of breast cancer, exercise, alcohol use, and consuming a traditional Hispanic or Latino diet were 




Table 3: Bivariate associations of reproductive and physiological variables with breast density 
Characteristic n (%) Dense 
Breasts  




(n = 760) 




Age at Menarche 
(Mean, SD) 
12.4 (2.03)   1.02 (0.96 – 1.09) 0.5400 1.00 (0.93 – 1.08) 0.9861 
Menopause Statusa        
    Perimenopausal 63 (6.2) 19 44 1.89 (1.06 – 3.36) <.0001e 1.37 (0.73 – 2.58) 0.0519 
    Premenopausal 344 (33.6) 141 203 3.04 (2.23 – 4.08)  1.66 (1.10 – 2.51)  
    Postmenopausal  618 (60.3) 115 503 1.00  1.00  
HRT Used         
    Yes 120 (11.8) 22 98 0.58 (0.36 – 0.94) 0.0259 0.77 (0.46 – 1.30) 0.3336 
    No 899 (88.2) 251 648 1.00  1.00  
Oral Contraceptive 
Use 
       
    >4 years 147 (14.5) 32 112 0.85 (0.55 – 1.31) 0.7298 0.77 (0.48 – 1.24) 0.4774 
    ≤4 years 442 (43.7) 119 323 0.99 (0.74 – 1.35)  0.86 (0.61 – 1.19)  
    Never used 423 (41.8) 114 309 1.00  1.00  
Oophorectomy        
    Yes 146 (14.4) 29 117 0.64 (0.41 – 0.98) 0.0416 0.86 (0.53 – 1.39) 0.5405 
    No 868 (85.6) 243 625 1.00    1.00  
Parity        
    ≥4 419 (40.8) 76 343 0.47 (0.20 – 1.13) <0.0001e 0.49 (0.19 – 1.29) 0.0004 
    <4 582 (56.7) 191 391 1.04 (0.44 – 2.45)  0.96 (0.37 – 2.46)  
    Nulliparous 25 (2.5) 8 17 1.00  1.00  
Age at first birth        
   ≥19 544 (53.1) 178 366 0.97 (0.46 – 2.05) <0.0001e 1.00 (0.44 – 2.23)  0.0007 
    <19 448 (43.7) 86 362 0.48 (0.22 – 1.02)  0.54 (0.24 – 1.22)  
    Nulliparous  33 (3.2) 11 22 1.00  1.00  
Months of 
Breastfeeding 
       
    ≥12 months 274 (27.2) 78 196 1.12 (0.80 – 1.57) 0.7533 1.00 (0.69 – 1.45) 0.8598 
    <12 months 289 (28.6) 75 214 0.99 (0.70 – 1.38)  0.91 (0.36 – 1.31)  
    Never 446 (44.2) 117 329 1.00  1.00  
History of Infertility        
   Yes 140 (13.7) 52 88 1.76 (1.21 – 2.57) 0.0031 1.32 (0.87 – 1.98) 0.1881 
   No 884 (86.3) 222 662 1.00  1.00  
Family History of 
Breast cancer 
       
   Yes 110 (12.2) 25 85 0.73 (0.46 – 1.17) 0.1938 0.89 (0.54 – 1.49) 0.6627 
   No 795 (87.9) 228 567 1.00    
BMI         
   Overweight 308 (31.0) 102 206 0.47 (0.31 – 0.71) <0.0001e -- -- 
   Obese 551 (55.5) 94 457 0.19 (0.13 – 0.29)    
   Normal/underweight 134 (13.5) 69 65 1.00    
Sum of 
comorbiditiesf 
       
    >3 290 (28.8) 45 245 0.32 (0.21 – 0.46) <0.0001e 0.59 (0.38 – 0.90)f 0.0917 f 
    3 182 (18.1) 47 135 0.59 (0.40 – 0.88)  0.71 (0.45 – 1.11)  
    2 210 (20.9) 60 150 0.68 (0.47 – 0.99)  0.76 (0.50 – 1.14)  
    0-1 324 (32.2) 120 204 1.00  1.00  
Diabeticf        
    Yes 522 (33.8) 58 297 0.40 (0.29 – 0.55) <0.0001 0.62 (0.43 – 0.90)f 0.0113 f 
    No 1023 (66.2) 213 435 1.00  1.00   
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aPostmenopausal group includes women with induced menopause.  
bp-values from chi-square tests.  
cAdjusted for BMI and age.  
dHRT, hormone replacement therapy. 
eSignificant trend p-value. 
fAdjusted with age, continuous BMI variable, and bra size. 
 
Adjusting for education, history of infertility, receipt of a mammogram in the last year, bra cup 
size, and parity, breast density was significantly associated with age at menarche, age, premenopausal 
status, diabetes, and BMI (Table 4). We observed a strong negative association between density, age, and 
BMI. Compared to women of normal weight, overweight and obese women were less likely to have dense 
breasts. Additionally, women over the age of 50 years old were at significantly reduced odds of dense 
breasts relative to women younger than 50 years old (OR = 0.48, 95% CI 0.30 – 0.78). We also observed 
an inverse relationship between age at menarche and breast density (OR = 0.89, 95% CI 0.81 – 0.98). In 
our multivariate model, premenopausal women were at 1.82 times the odds of having dense breasts (95% 
CI 1.13 – 2.92) compared to women who were postmenopausal. Perimenopausal women were also at 
increased odds of density (OR = 1.36, 95% CI 0.65 – 2.83), however this association was not significant. 
Interestingly, the protective effect of diabetes persisted in the multivariate model. Our findings showed 
that women with diabetes had significantly reduced odds of dense breasts relative to women without 
diabetes (OR=0.62, 95% CI 0.41 – 0.90). Although having children before or after the age of 19 years old 
Bra Size        
    DD or larger 53 (5.2) 6 47 0.11 (0.40 – 0.31) <0.0001e 0.21 (0.22 – 0.41) 0.0267 
    D 223 (22.0) 47 176 0.23 (0.12 – 0.46)  0.36 (0.17 – 0.74)  
    C 343 (3.8) 87 256 0.30 (0.16 – 0.56)  0.42 (0.21 – 0.85)  
    B 350 (34.5) 110 240 0.40 (0.21 – 0.75)  0.49 (0.25 – 0.99)  
    A 45 (4.4) 24 21 1.00  1.00  
Exercise Once per 
week 
       
    Yes 430 (44.4) 122 308 1.09 (0.82 – 1.45) 0.5344 1.05 (0.77 – 1.43) 0.7623 




       
    Everyday 549 (61.9) 162 387 1.84 (0.67 – 4.95) 0.0754e 1.12 (0.39 – 3.25) 0.3215 
    4-6 times/week 129 (14.6) 42 87 2.12 (0.75 – 6.00)  1.28 (0.42 – 3.93)  
    1-3 times/week 181 (20.4) 39 142 1.21 (0.43 – 3.40)  0.78 (0.26 -2.38)  
    Less than weekly 27 (3.1) 5 22 1.00  1.00  
Alcohol 
Consumption 
       
    Yes 230 (24.0) 68  162 1.15 (0.83 – 1.59) 0.4169 0.95 (0.67 – 1.37) 0.8059 
    No 727 (76.0) 195 532 1.00  1.00  
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appeared protective from breast density compared to being nulliparous, these associations were not 
statistically significant.  
 
























aAdjusted for education, history of infertility, receipt of mammogram in the last year, bra cup size, and parity.  
 
We tested for interactions between age, BMI, and significant variables in the multivariate model. 
There was evidence of an interaction between age at menarche and BMI (Table 5, Figure 2). Normal and 
underweight women who experienced menarche before the age of 12, were at 1.92 times the odds of 
having dense breasts relative to women who experienced menarche after age 12. Conversely, obese and 
overweight women who experienced menarche earlier were at reduced odds of dense breasts relative to 
obese and overweight women who began menstruating at an older age. We analyzed this interaction term 
within the final multivariate model, however, adding the term worsened the overall model fit. 
Consequently, we reported the results from the stratified analysis and Breslow-Day test for homogeneity 
(p-value = 0.049). 
  
  
Characteristic OR 95% CI 
Age at Menarche 0.89 0.81 – 0.98 
Age   
    ≥50 0.48 0.30 – 0.78 
    <50 1.00 -- 
Age at first birth   
   ≥19 0.46 0.06 – 3.42 
   <19 0.29 0.04 – 2.18 
   Nulliparous 1.00 -- 
Menopause Status   
   Premenopausal 1.82 1.13 – 2.92 
   Perimenopausal 1.36 0.65 – 2.83 
   Postmenopausal 1.00 -- 
Diabetes   
   Yes 0.62 0.41 – 0.95 
   No 1.00 -- 
BMI   
   Overweight 0.53 0.31 – 0.90 
   Obese 0.23 0.13 – 0.38 




Table 5: Results from stratified analysis of age at menarche and breast density by BMI 
BMI Category OR 95% CI p-valuea 
Normal/Underweight 1.93 0.97 - 3.84 
0.049 Overweight/Obese 0.9 0.65 - 1.24 
Common  1.03 0.77 - 1.38 




 In this study we aimed to identify predictors of breast density, an important risk factor for breast 
cancer, in Hispanic and Latino women living in Connecticut. Unlike other studies in which cross sectional 
study designs were utilized to examine breast density in Hispanic and Latino women, we followed 
participants prospectively in order to uncover potential factors that give rise to density. Additionally, this 
study focused primarily on women living in the Northeast region of the United States. Considering the 
limited data on this particular population, we comprehensively examined a number of breast cancer risk 
factors, known predictors of breast density, and sociodemographic variables. Our multivariate analyses 
showed associations of breast density with age, BMI, age at menarche, diabetes, and premenopausal 
0	 0.5	 1	 1.5	 2	 2.5	 3	 3.5	 4	
Odds	RaMo	and	95%	Wald	Confidence	Limits	
Figure 2: Interac.ons Between Age at Menarche and BMI, 







status adjusting for education, history of infertility, receipt of mammogram in the last year, bra cup size, 
and parity. We also observed a potential interaction between age at menarche and BMI.  
Breast density predictors in Hispanic and Latino women identified in this study including age, 
BMI, menopause status, and age at menarche are consistent with previously reported studies (14, 22-24). 
Although risk factors across populations appear comparable, we note that the overall distribution of breast 
density among our study population differs from that of the general population. Our results showed that of 
women for whom density data were collected, only 25% had dense breasts (2% extremely dense and 25% 
heterogeneously dense). The American College of Radiology, however, report that in the general 
population, 50% of women have dense breasts (10% extremely and 40% heterogeneous) (25). This 
variation in breast density distribution may, in part, explain lower breast cancer incidence among 
Hispanic and Latino women compared to White and Black women. Further investigation is required to 
understand contributing factors to these distributional differences and determine if lower breast density is 
a potential driver of reduced breast cancer risk in this population. 
Despite its association with increased breast cancer risk, BMI is significantly inversely associated 
with dense breasts (12, 14, 26). Obese and overweight women have a lower ratio of dense to fatty tissue 
in the breast relative to normal weight women (26). Studies indicate that fatty breasts may be protective 
against breast cancer, possibly as a result of fewer epithelial and stromal cells in the breast that could give 
rise to cancerous tumors (5, 9). Obese and overweight women may also have larger breasts relative to 
women of normal weight. We’ve shown that increasing bra size is associated with decreased odds of 
dense breasts and studies suggest that the effect of density on breast cancer risk is lower among women 
with larger breasts relative to women with smaller breasts (27). Controlling for bra size however, we’ve 
shown an independent protective effect of higher BMI on breast density. BMI and breast size may be 
related, but they appear to operate independently of one another as predictors of breast density.  
Our findings also suggest an interaction between age at menarche and BMI. Among normal 
weight women, experiencing menarche before the age of 12 is associated with a two fold increase in the 
odds of having dense breasts relative to women who began menses over the age of 12. Among obese 
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women however, the effect of early age at menarche is truncated by the effect of obesity. These women 
are protected against dense breasts even if they experience menarche earlier. This finding has implications 
for the relative importance of each of these breast density predictors as it appears the effect of BMI is 
stronger than that of age at menarche.  
Among other variables included in the analysis is diabetes, which is suggested to be a weak risk 
factor for breast cancer, although the biological mechanism of disease has yet to be identified (28-30). In 
contrast, in our population, diabetes was associated with a decrease in odds of dense breasts. Previous 
studies examining the relationship between diabetes and breast density yielded conflicting results. Among 
Native American women, diabetes was similarly shown to have a negative relationship with dense 
breasts, however this was only significant among premenopausal women (31). Other studies report no 
association between density and diabetes (28, 32). Discrepancies between studies could be a result of 
differences in outcome classification (categorized versus quantitative measures of breast density) or 
ethnic differences among study populations (28, 32). Of the women in our study population who were 
diabetic, 94% reported taking insulin, other oral medication, or both. The use of diabetes medication may 
explain the relationship we observed in our investigation. Studies are currently underway to examine the 
effect of the diabetes medication, metformin, on breast density (33). 
Strengths of this investigation include the use of a prospective cohort study design. In using this 
design we may establish temporality between significant predictors and breast density. Additionally, the 
baseline questionnaire allowed for the collection of a comprehensive set of variables for the study 
including sociodemographic, reproductive, and physiological data (as well information on potential 
confounders) on the cohort. One limitation of our study involves the subjective assessment of breast 
density. We ascertained our outcome from mammography reports retrieved from screening facilities 
throughout Connecticut. The BI-RADS categorization listed on the report provided the radiologists’ 
classification of density, which we used to further categorize our cohort as “dense” and “nondense”. BI-
RADS is a qualitative method used in determining breast density and reporting is not protected against 
potential bias or variation in radiologist reporting. Automated quantitation may assist in obtaining 
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accurate and objective measurements of breast density in future studies (34). Another limitation to the 
study involves changes in breast density over time. We collected mammography reports from screening 
facilities throughout the follow-up period. Breast density has been shown to decline over time (i.e. with 
age) and we generally assumed breast density would not increase over the follow-up period (22, 23). As 
such, if a woman was reported as having nondense breasts earlier in follow-up but was later reported to be 
dense (based on reports received later in follow-up), she was categorized as having nondense breasts. 
While such changes in density categorization were likely a result of variation in radiologist reporting, this 
impacted very few women in our study (n=11).  
This study provided an opportunity to examine breast density in the population of Hispanic and 
Latino women living in the Northeast region of the United States. Additionally, this investigation gives 
insight to a population in which prevalence of diabetes and comorbidity is high relative to the overall 
population of the United States (35). Breast density predictors in our cohort are consistent with predictors 
in the general population. We report, however, that the distribution of density in our cohort differs from 
that of the general population and may explain lower breast cancer risk among Hispanic and Latino 
women. We also found a significant inverse association between density and diabetes. Although there is 
some discrepancy among previous findings, this may be a unique phenomenon among this population that 
elicits further study along with the potential impact of diabetes medication use on density. Our results also 
suggest that the effect of age at menarche may be modified by BMI. In describing the breast density 
distribution in Hispanic and Latino women and identifying risk factors in this population, these findings 
not only add to the body of breast density literature but also promote our understanding of density in this 
understudied population and provide evidential basis for future breast density research. 
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